Company Filing History:
Years Active: 2012-2023
Title: Randal May: Innovator in Antibody Research
Introduction
Randal May is a prominent inventor based in Oklahoma City, OK (US). He has made significant contributions to the field of antibody research, holding a total of 3 patents. His work focuses on developing innovative solutions for medical applications, particularly in the realm of cancer research.
Latest Patents
Randal May's latest patents include groundbreaking advancements in the use of antibodies. One of his notable patents is for "Anti-doublecortin-like kinase 1 antibodies and methods of use." This patent discloses antibodies and antigen-binding fragments that specifically bind to the human DCLK1 protein. It also covers hybridomas or other cell lines that express such antibodies, as well as nucleic acids, vectors, and host cells that comprise nucleic acids encoding these antibodies. The patent emphasizes the specificity of these antibodies for certain epitopes within isoform 2 or 4 of the DCLK1 protein.
Another significant patent is for "Anti-DCLK1 monoclonal antibodies and methods of production and use thereof." This patent details monoclonal antibodies against DCLK1 and the conjugates containing these antibodies. It also outlines methods for producing and utilizing these monoclonal antibodies, showcasing Randal May's commitment to advancing therapeutic options in cancer treatment.
Career Highlights
Randal May is affiliated with the University of Oklahoma, where he conducts his research and development work. His academic background and professional experience have positioned him as a leader in his field. His innovative approaches to antibody development have garnered attention and respect within the scientific community.
Collaborations
Randal May collaborates with esteemed colleagues, including Courtney W Houchen and Sripathi M Sureban. These partnerships enhance the research efforts and contribute to the advancement of knowledge in the field of antibody research.
Conclusion
Randal May's contributions to antibody research are noteworthy, with a focus on developing innovative solutions for medical applications. His patents reflect a commitment to advancing cancer treatment through scientific innovation. His work continues to inspire and pave the way for future advancements in the field.